Abstract:The ubiquitin cascade involves three families of enzymes that activate, conjugate, and ligate ubiquitin to substrate proteins. Ubiquitin attachment can promote the degradation of substrates but also has other critical roles in cells. Here, we have used phage display to discover six ubiquitin variants (UbVs) that bind to and inhibit an E2 enzyme. Our work may form the framework for the discovery of new therapeutics as well as provide new research tools. The ubiquitin‐conjugating E2 enzymes play a central role in ubiquitin transfer. Disruptions to the ubiquitin system are implicated in multiple diseases, and as a result, molecules that modulate the activity of the ubiquitin system are of interest. E2 enzyme function relies on interactions with partner proteins, and the disruption of these is an effective way to modulate activity. Here, we report the discovery of ubiquitin variants (UbVs) that inhibit the E2 enzyme, Ube2d2 (UbcH5b). The six UbVs identified inhibit ubiquitin chain building, and the structural and biophysical characterisation of two of these demonstrate they bind to Ube2d2 with low micromolar affinity and high specificity. Both characterised UbVs bind at a site that overlaps with E1 binding, while the more inhibitory UbV has an additional binding site that blocks a critical non‐covalent ubiquitin‐binding site on the E2 enzyme. The discovery of novel protein‐based ubiquitin derivatives that inhibit protein–protein interactions is an important step towards discovering small molecules that inhibit the activity of E2 enzymes. Furthermore, the specificity of the UbVs within the Ube2d family suggests that it may be possible to develop tools to selectively inhibit highly related E2 enzymes.

E2 Enzyme Inhibition by Stabilization of a Low-Affinity Interface with Ubiquitin.

Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2

Structural and biophysical characterisation of ubiquitin variants that specifically inhibit the ubiquitin conjugating enzyme Ube2d2

Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site

Highly specific intracellular ubiquitination of a small molecule

Reconstitution and Structural Analysis of a HECT Ligase-Ubiquitin Complex via an Activity-Based Probe

Design of linked-domain protein inhibitors of UBE2D as tools to study cellular ubiquitination

A Strategy for Modulation of Enzymes in the Ubiquitin System

Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1

A Modular Turn‐On Strategy to Profile E2‐Specific Ubiquitination Events in Living Cells

Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade

Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor

Insights into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.

Protein semisynthesis reveals plasticity in HECT E3 ubiquitin ligase mechanisms

Targeting UBE2C for Degradation by Bioprotacs Based on Bacterial E3 Ligase

Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6

Getting into position: the catalytic mechanisms of protein ubiquitylation

Kinetic Constraints in the Specific Interaction Between Phosphorylated Ubiquitin and Proteasomal Shuttle Factors

Allosteric Regulation of E2:E3 Interactions Promote A Processive Ubiquitination Machine

Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System

Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1